FBLG
FibroBiologics·NASDAQ
--
--(--)
--
--(--)
6.60 / 10
Outperform
Analyst coverage is bullish with both analysts issuing Strong Buy ratings. Fund-flow metrics are favorable (7.86/10), showing net inflows across most categories except Large blocks. This positive sentiment and capital support contrast with the weak fundamentals and poor technical setup.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-06
InstitutionD. Boral Capital
Times predicted14
Historical Win Rate42.9%
What is the analyst consensus for FBLG?
- FBLG holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 6.60/10 (Outperform).
